Republished viewpoint: Diabetes-induced osteoarthritis: From a new paradigm to a new phenotype

Postgraduate Medical Journal

Volumn 88, Issue 1038, 2011, Pages 240-242

  Berenbaum, Francis ^a  

^a SORBONNE UNIVERSITÉ   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADVANCED GLYCATION END PRODUCT; REACTIVE OXYGEN METABOLITE; SOMATOMEDIN C;

ADIPOSE TISSUE; ARTICLE; CARDIOVASCULAR RISK; CARTILAGE CELL; CELL METABOLISM; DIABETES MELLITUS; DISEASE ASSOCIATION; DISEASE COURSE; HUMAN; HYPERGLYCEMIA; HYPOPHYSECTOMY; JOINT PROSTHESIS; METABOLIC SYNDROME X; MOTOR DYSFUNCTION; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OSTEOARTHRITIS; SENSORY DYSFUNCTION;

EID: 84859086298     PISSN: 00325473     EISSN: 14690756     Source Type: Journal    
DOI: 10.1136/pgmj.2010.146399rep     Document Type: Article

References (37)

1. Herrero-Baaumont G, Roman-Blas JA, Castañeda S, etal. Primary osteoarthritis no longer primary: three subsets with distinct etiological, clinical, and therapeutic characteristics. Semin Arthritis Rheum 2009;39:71-80.
2. Pottie P, Presle N, Terlain B, et al. Obesity and osteoarthritis: more complex than predicted Ann Rheum Dis 2006;65:1403-5.
3. Cadwell BL, Thompson TJ, Boyle JR et al. Bayesian small area estimates of diabetes prevalence by U.S. County, 2005. J Data Sei 2010;8:173-88.
4. Engström G, Gerhardsson de Verdier M, Rollof J, et al. C-reactive protein, metabolic syndrome and incidence of severe hip and knee osteoarthritis. A population-based cohort study. Osteoarthr Cartii 2009;17:168-73.
5. Velasquez MT, Katz JD. Osteoarthritis: another component of metabolic syndrome? Metab Syndr Reiat Disord 2010;8:295-305.
6. Puenpatom RA, Victor TW. Increased prevalence of metabolic syndrome in individuals with osteoarthritis: an analysis of NHANES III data. Postgrad Med 2009;121:9-20.
7. Waine H, Nevinny D, Rosenthal J, etal. Association of osteoarthritis and diabetes mellitus. Tufts Folia Med 1961;7:13-19.
8. Stürmer T, Brenner H, Brenner RE, et al. Non-insulin dependent diabetes mellitus (NIDDM) and patterns of osteoarthritis. The Ulm osteoarthritis study. ScandJ Rheumatol 2001;30:169-71.
9. Cimmino MA, Cutolo M. Plasma glucose concentration in symptomatic osteoarthritis: a clinical and epidemiological survey. Clin Exp Rheumatol 1990;8:251-7.
10. Hart DJ, Doyle DV, Spector TD. Association between metabolic factors and knee osteoarthritis in women: the Chingford Study. J Rheumatol 1995;22:1118-23.
11. Schett G, Kiechl S, Bonora E, et al. Vascular cell adhesion molecule 1 as a predictor of severe osteoarthritis of the hip and knee joints. Arthritis Rheum 2009;60:2381-9.
12. Frey Ml, Barrett-Connor E, Sledge PA, et al. The effect of noninsulin dependent diabetes mellitus on the prevalence of clinical osteoarthritis. A population based study. J Rheumatol 1996;23:716-22.
13. Andereon JJ, Felson DT. Factors associated with osteoarthritis of the knee in the first national Health and Nutrition Examination Survey (HANES I). Evidence for an association with overweight, race, and physical demands of work. Am J Epidemiol 1988;128:179-89.
14. Maroudas A, Bullough R Swanson SA, et al. The permeability of articular cartilage. J Bone Joint Surg Br 1968;50:166-77.
15. Mobasheri A, Bondy CA, Moley K, et al. Facilitate glucose transporters in articular chondrocytes. Expression, distribution and functional regulation of GLUT isoforms by hypoxia, hypoxia mimetics, growth factors and pro-inflammatory cytokines. AdvAnat Embryol Cell Biol 2008;200:1 p following vi, 1-84.
16. Shikhman AR, Brinson DC, Valbracht J, et al. Cytokine regulation of facilitated glucose transport in human articular chondrocytes. J Immunol 2001;167:7001-8.
17. McNulty AL, Stabler TV, Vail TR et al. Dehydroascorbate transport in human chondrocytes is regulated by hypoxia and is a physiologically relevant source of ascorbic acid in the joint. Arthritis Rheum 2005;52:2676-85.
18. Henrotin YE, Bruckner R Pujol JR The role of reactive oxygen species in homeostasis and degradation of cartilage. Osteoarthr Cartii 2003; 11:747-55.
19. Rosa SC, Gongalves J, Judas F, et al. Impaired glucose transporter-1 degradation and increased glucose transport and oxidative stress in response to high glucose in chondrocytes from osteoarthritic versus normal human cartilage. Arthritis Res Ther 2009;11:R80.
20. Ramasamy R, Vannucci SJ, Yan SS, et al. Advanced glycation end products and RAGE: a common thread in aging, diabetes, neurodegeneration, and inflammation. Glycobiology 2005;15:16R-28R.
21. Brownlee M, Cerami A, Vlassara H. Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications. N Engl J Med 1988;318:1315-21.
22. Verzijl N, De Groot J, Ben ZC, et al. Crosslinking by advanced glycation end products increases the stiffness of the collagen network in human articular cartilage: a possible mechanism through which age is a risk factor for osteoarthritis. Arthritis Rheum 2002;46:114-23.
23. Yan SF, Ramasamy R, Schmidt AM. The RAGE axis: a fundamental mechanism signaling danger to the vulnerable vasculature. Circ Res 2010;106:842-53.
24. Steenvoorden MM, Huizinga TW, Verzijl N, et al. Activation of receptor for advanced glycation end products in osteoarthritis leads to increased stimulation of chondrocytes and synoviocytes. Arthritis Rheum 2006;54:253-63.
25. Cecil DL, Johnson K, Rediske J, et al. Inflammation-induced chondrocyte hypertrophy is driven by receptor for advanced glycation end products. J Immunol 2005;175:8296-302.
26. Looser RF, Yammani RR, Carlson CS, et al. Articular chondrocytes express the receptor for advanced glycation end products: Potential role in osteoarthritis. Arthritis Rheum 2005;52:2376-85.
27. Kelley KM, Russell SM, Matteucci ML, et al. An insulin-like growth factor l-resistant state in cartilage of diabetic rats is ameliorated by hypophysectomy. Possible role of metabolism. Diabetes 1993;42:463-9.
28. Atayde SA, Andrade PC, Catanozi S, et al. Synovial extracellular matrix remodeling in experimental model of diabetes. Arthritis Rheum 2010;62 Suppl 10:S368.
29. Hurley MV. The role of muscle weakness in the pathogenesis of osteoarthritis. Rheum Dis Clin North Am 1999;25:283-98.
30. Slemenda C, Brandt KD, Heilman DK, et al. Quadriceps weakness and osteoarthritis of the knee. Ann Intern Med 1997;127:97-104.
31. Shakoor N, Lee KJ, Fogg LF, et al. Generalized vibratory deficits in osteoarthritis of the hip. Arthritis Rheum 2008;59:1237-40.
32. van Sloten TT, Savelberg HH, Duimel-Peeters IG, et al. Peripheral neuropathy, decreased muscle strength and obesity are strongly associated with walking in persons with type 2 diabetes without manifest mobility limitations. Diabetes Res Clin Pract 2011;91:32-9.
33. Esposito K, Nappo F, Marfella R, et al. Inflammatory cytokine concentrations are acutely increased by hyperglycemia in humans: role of oxidative stress. Circulation 2002;106:2067-72.
34. Ling PR, Mueller C, Smith RJ, et al. Hyperglycemia induced by glucose infusion causes hepatic oxidative stress and systemic inflammation, but not STAT3 or MAP kinase activation in liver in rats. Metab Clin Exp 2003;52:868-74.
35. Yemeni KK, Bai W, Khan BV, et al. Hyperglycemia-induced activation of nuclear transcription factor kappaB in vascular smooth muscle cells. Diabetes 1999;48:855-64.
36. Igarashi M, Wakasaki H, Takahara N, et al. Glucose or diabetes activates p38 mitogen-activated protein kinase via different pathways. J Clin Invest 1999;103:185-95.
37. Stannus O, Jones G, Cicuttini F, et al. Circulating levels of IL-6 and TNF-a are associated with knee radiographic osteoarthritis and knee cartilage loss in older adults. Osteoarthr Cartii 2010;18:1441-7.